More on MBX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (9.2 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

MBX Biosciences (NQ:MBX)
Delayed: 60.93 -0.67 (1.09%)
Prev. Close $61.60  
Open$61.42 
52 Wk High$ 
52 Wk Low$ 
Day High$62.88 
Day Low$60.22 
P/E N/A  
EPS$ 
Volume416,087 

Friends, Peers and Foes (?): MBXBF, ARQT, GNLX, NAMS, AEMD (more...)

Aug 27, 2026 08:35 AM Form 8-K MBX Biosciences, Inc. For: Aug 27
Aug 27, 2026 08:01 AM MBX Biosciences doses first patient in Phase 3 hypoparathyroidism trial
Aug 27, 2026 08:00 AM MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism
Aug 21, 2026 03:27 AM JPMorgan Reinstates MBX Biosciences Inc (MBX) at Overweight
Aug 17, 2026 03:41 PM Form 144 MBX Biosciences, Inc. Filed by: Hawryluk P. Kent
Aug 14, 2026 08:28 AM Form SCHEDULE 13G/A MBX Biosciences, Inc. Filed by: Deep Track Capital, LP
Aug 10, 2026 05:36 PM Form SCHEDULE 13D/A MBX Biosciences, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
Aug 10, 2026 04:44 PM Form SCHEDULE 13D/A MBX Biosciences, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 10, 2026 07:22 AM MBX Biosciences Inc (MBX) PT Raised to $88 at Truist Securities
Aug 10, 2026 04:22 AM MBX Biosciences Inc (MBX) PT Raised to $88 at Barclays
View All Articles

Entities mentioned with MBX

View All Entities